Vice President of Regulatory Strategy
NAMSA/Syntactx
New York, New York, United States
Dorothy Abel is a biomedical engineer, member of AIMBE, and former senior scientific reviewer in the Vascular Surgery Devices Branch in the Office of Device Evaluation at the Food and Drug Administration (FDA) in White Oak, Maryland. She has more than 30 years of medical device regulatory experience, primarily with vascular and endovascular prostheses. She was a primary author on the Early Feasibility Study IDE Guidance with Dr. Andrew Farb. She was also active in the development of the CDRH Innovation Pathway and participated in the White House supported Entrepreneurs in Residence Program. Currently Ms. Abel is the Vice President of Regulatory Strategy for NAMSA.
Tuesday, February 28, 2023
8:00 AM – 9:35 AM ET
Disclosure(s): multiple: Consultant (Ongoing)
Tuesday, February 28, 2023
8:48 AM – 9:15 AM ET
Disclosure(s): multiple: Consultant (Ongoing)